Cellectar Biosciences Inc. (CLRB)
NASDAQ: CLRBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Pre-market: 1.50 -0.66%
CLRB stock chart
Technical analysisKey statistics
All statistics- Market cap
- $14.27M
- EPS (TTM)
- -$3.46
- Dividend yield
- None
- 52-week range
- 1.46 – 5.07
- Day range
- 1.47 – 1.62
- Volume / Avg
- 42.63K / 61.52K
- Beta
- —
- Shares outstanding
- 9.45M
52-week range
CLRB stock today
Cellectar Biosciences (CLRB) closed at $1.51 on Oct 7, essentially unchanged from the prior close, versus the S&P 500's 0.22% decline. Shares are 70.2% below their 52-week high of $5.07 and 3.4% above the 52-week low of $1.46, near the bottom of the past year's range. CLRB is down 48.8% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 70.6%.
Cellectar Biosciences has posted a net loss over the last twelve months (EPS of -$3.46), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Cellectar Biosciences
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Headquarters
- Florham Park, NJ
Cellectar Biosciences peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| HINDVyome Holdings Inc. | 2.04 | -0.97% | $14.32M | vs CLRB |
| KPTIKaryopharm Therapeutics Inc. | 0.645 | -0.75% | $14.63M | vs CLRB |
| BFRIBiofrontera Inc. | 0.9354 | +0.36% | $13.89M | vs CLRB |
| TVRDTvardi Therapeutics Inc. | 1.10 | +1.85% | $14.67M | vs CLRB |
| CTXRCitius Pharmaceuticals Inc. | 0.5011 | +4.24% | $13.76M | vs CLRB |
| KTTAPasithea Therapeutics Corp. | 0.4434 | -0.81% | $14.82M | vs CLRB |
| LTRNLantern Pharma Inc. | 0.91 | -4.58% | $13.59M | vs CLRB |
| TPSTTempest Therapeutics Inc. | 0.7914 | +0.50% | $13.37M | vs CLRB |
Indexes, lists and sector
Cellectar Biosciences stock FAQ
What is Cellectar Biosciences's stock price today?
CLRB last traded at $1.51 as of Oct 7, 4:00 PM EDT, up 0.00% on the day. Prices are delayed at least 15 minutes.
Does Cellectar Biosciences pay a dividend?
No. Cellectar Biosciences does not currently pay a regular cash dividend.
Has CLRB ever split its stock?
Yes. The most recent CLRB stock split was a 1-for-30 split on Jun 24, 2025, one of 6 splits on record.
What is the CLRB 52-week high?
The 52-week high for CLRB is $5.07 and the 52-week low is $1.46. The stock is currently 70.2% below its high.